Literature DB >> 26077919

Rheumatoid arthritis: Biomarkers of response to TNF inhibition in RA.

Prabha Ranganathan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26077919     DOI: 10.1038/nrrheum.2015.83

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  9 in total

1.  GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis.

Authors:  Isabel Acosta-Colman; Núria Palau; Jesús Tornero; Antonio Fernández-Nebro; Francisco Blanco; Isidoro González-Alvaro; Juan D Cañete; Joan Maymó; Javier Ballina; Benjamín Fernández-Gutiérrez; Alex Olivé; Héctor Corominas; Alba Erra; Oriol Canela-Xandri; Arnald Alonso; Maria López Lasanta; Raül Tortosa; Antonio Julià; Sara Marsal
Journal:  Pharmacogenomics       Date:  2013-05       Impact factor: 2.533

2.  Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis.

Authors:  A Ferreiro-Iglesias; A Montes; E Perez-Pampin; J D Cañete; E Raya; C Magro-Checa; Y Vasilopoulos; T Sarafidou; R Caliz; M A Ferrer; B Joven; P Carreira; A Balsa; D Pascual-Salcedo; F J Blanco; M J Moreno-Ramos; A Fernández-Nebro; M C Ordóñez; J J Alegre-Sancho; J Narváez; F Navarro-Sarabia; V Moreira; L Valor; R García-Portales; A Marquez; J Martin; J J Gómez-Reino; A Gonzalez
Journal:  Pharmacogenomics J       Date:  2015-04-21       Impact factor: 3.550

3.  A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis.

Authors:  A Julià; A Fernandez-Nebro; F Blanco; A Ortiz; J D Cañete; J Maymó; M Alperi-López; B Fernández-Gutierrez; A Olivè; H Corominas; A Erra; I Acosta-Colman; A Alonso; M López-Lasanta; R Tortosa; J Tornero; S Marsal
Journal:  Pharmacogenomics J       Date:  2015-04-21       Impact factor: 3.550

4.  Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Authors:  K L Hyrich; K D Watson; A J Silman; D P M Symmons
Journal:  Rheumatology (Oxford)       Date:  2006-05-16       Impact factor: 7.580

5.  Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy.

Authors:  Jing Cui; Saedis Saevarsdottir; Brian Thomson; Leonid Padyukov; Annette H M van der Helm-van Mil; Joanne Nititham; Laura B Hughes; Niek de Vries; Soumya Raychaudhuri; Lars Alfredsson; Johan Askling; Sara Wedrén; Bo Ding; Candace Guiducci; Gert Jan Wolbink; J Bart A Crusius; Irene E van der Horst-Bruinsma; Marieke Herenius; Michael E Weinblatt; Nancy A Shadick; Jane Worthington; Franak Batliwalla; Marlena Kern; Ann W Morgan; Anthony G Wilson; John D Isaacs; Kimme Hyrich; Michael F Seldin; Larry W Moreland; Timothy W Behrens; Cornelia F Allaart; Lindsey A Criswell; Tom W J Huizinga; Paul P Tak; S Louis Bridges; Rene E M Toes; Anne Barton; Lars Klareskog; Peter K Gregersen; Elizabeth W Karlson; Robert M Plenge
Journal:  Arthritis Rheum       Date:  2010-07

6.  Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis.

Authors:  Prabha Ranganathan; Robert Culverhouse; Sharon Marsh; Ami Mody; Tiffany J Scott-Horton; Richard Brasington; Amy Joseph; Virginia Reddy; Seth Eisen; Howard L McLeod
Journal:  J Rheumatol       Date:  2008-03-15       Impact factor: 4.666

7.  Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis.

Authors:  L Padyukov; J Lampa; M Heimbürger; S Ernestam; T Cederholm; I Lundkvist; P Andersson; Y Hermansson; A Harju; L Klareskog; J Bratt
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

8.  Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.

Authors:  C Potter; K L Hyrich; A Tracey; M Lunt; D Plant; D P M Symmons; W Thomson; J Worthington; P Emery; A W Morgan; A G Wilson; J Isaacs; A Barton
Journal:  Ann Rheum Dis       Date:  2008-03-28       Impact factor: 19.103

9.  Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis.

Authors:  Jing Cui; Eli A Stahl; Saedis Saevarsdottir; Corinne Miceli; Dorothee Diogo; Gosia Trynka; Towfique Raj; Maša Umiċeviċ Mirkov; Helena Canhao; Katsunori Ikari; Chikashi Terao; Yukinori Okada; Sara Wedrén; Johan Askling; Hisashi Yamanaka; Shigeki Momohara; Atsuo Taniguchi; Koichiro Ohmura; Fumihiko Matsuda; Tsuneyo Mimori; Namrata Gupta; Manik Kuchroo; Ann W Morgan; John D Isaacs; Anthony G Wilson; Kimme L Hyrich; Marieke Herenius; Marieke E Doorenspleet; Paul-Peter Tak; J Bart A Crusius; Irene E van der Horst-Bruinsma; Gert Jan Wolbink; Piet L C M van Riel; Mart van de Laar; Henk-Jan Guchelaar; Nancy A Shadick; Cornelia F Allaart; Tom W J Huizinga; Rene E M Toes; Robert P Kimberly; S Louis Bridges; Lindsey A Criswell; Larry W Moreland; João Eurico Fonseca; Niek de Vries; Barbara E Stranger; Philip L De Jager; Soumya Raychaudhuri; Michael E Weinblatt; Peter K Gregersen; Xavier Mariette; Anne Barton; Leonid Padyukov; Marieke J H Coenen; Elizabeth W Karlson; Robert M Plenge
Journal:  PLoS Genet       Date:  2013-03-28       Impact factor: 5.917

  9 in total
  2 in total

Review 1.  Genomics and epigenomics in rheumatic diseases: what do they provide in terms of diagnosis and disease management?

Authors:  Patricia Castro-Santos; Roberto Díaz-Peña
Journal:  Clin Rheumatol       Date:  2017-07-20       Impact factor: 2.980

Review 2.  Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses.

Authors:  Silvia Menegatti; Elisabetta Bianchi; Lars Rogge
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.